Skip to main content
II

Insomnia Intelligence

Insomnia Intelligence offers Evolv28, a daytime wearable neckband that emits a patented Variable Complex Magnetic Fields (VCMF™) signal to reduce hyperarousal in the nervous system.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Insomnia is often driven by chronic hyperarousal of the nervous system, a brain state that conventional sleep aids, tracking devices, and behavioral therapies do not directly address, leaving many sufferers unable to fall asleep naturally.

Solution

Evolv28 is a daytime wearable neckband that emits a patented Variable Complex Magnetic Fields (VCMF™) signal in the 8–30 Hz range. The never‑repeating magnetic pattern gently reduces the brain’s “stay‑awake” signaling via the reticular activating system, allowing the nervous system to calm before bedtime. Clinical trials published in peer‑reviewed journals show an average increase of 45 minutes of total sleep time, faster sleep onset, and a 7.2‑point reduction on the Insomnia Severity Index, with zero major adverse events. The device operates silently, without electrodes or sensation, and integrates invisibly into daily activities, delivering a non‑pharmacological solution that prepares users for natural sleep onset.

Target Audience

Primary customers are adults with chronic insomnia driven by hyperarousal who seek a non‑pharmacological, daytime solution, including sleep clinics, wellness providers, and individuals dissatisfied with pills, trackers, or standard CBT‑I.

Features

  • Patented VCMF™ technology delivering a non‑repeating 8–30 Hz magnetic field that the brain cannot adapt to
  • Lightweight cervical neckband design that is silent, sensation‑free, and wearable during normal daytime activities
  • Clinically validated efficacy: +45 min average sleep gain, ~20 min faster sleep onset, and ≥7‑point ISI reduction in a sham‑controlled RCT
  • Ultra‑low magnetic intensity (<1 µT) compliant with international safety guidelines and cleared in US, EU, Canada, and India
  • Simple protocol: minimum 4 hours per day for 28 days, with a full‑refund guarantee if no meaningful improvement is observed
This profile is AI-generated and may contain inaccuracies.